Systemic redox imbalance in stable chronic obstructive pulmonary disease

References

• Ahmad A, Shameem M, Husain Q. (2013). Altered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 17:1104–9.
   PubMed Web of Science ®Google Scholar
• Altamura C, Squitti R, Pasqualetti P, et al. (2009). Ceruloplasmin/transferrin system is related to clinical status in acute stroke. Stroke 40:1282–8.
   PubMed Web of Science ®Google Scholar
• Arja C, Surapaneni KM, Raya P, et al. (2013). Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease. Respirology 18:1069–75.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Chowdhury B, Kharitonov SA, et al. (2006). Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:6–14.
   PubMed Web of Science ®Google Scholar
• Barreiro E, Fermoselle C, Mateu-Jimenez M, et al. (2013). Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD. Free Radic Biol Med 65:859–71.
   PubMed Web of Science ®Google Scholar
• Ben Moussa S, Sfaxi I, Tabka Z, et al. (2014). Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study. Libyan J Med 9:23873.
   PubMed Web of Science ®Google Scholar
• Biljak VR, Rumora L, Čepelak I, et al. (2010). Glutathione cycle in stable chronic obstructive pulmonary disease. Cell Biochem Funct 28:448–53.
   PubMed Web of Science ®Google Scholar
• Burtis CA, Ashwood ER, Bruns DE. (2012). Tietz textbook of clinical chemistry and molecular diagnostics. 5th ed. St. Louis, USA: Elsevier Saunders.
   Google Scholar
• Dalle-Donne I, Rossi R, Colombo R, et al. (2006). Biomarkers of oxidative damage in human disease. Clin Chem 52:601–23.
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. (2012). Chronic obstructive pulmonary disease. Lancet 379:1341–51.
   PubMed Web of Science ®Google Scholar
• Domej W, Oettl K, Renner W. (2014). Oxidative stress and free radicals in COPD – implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis 9:1207–24.
   PubMed Web of Science ®Google Scholar
• Domijan AM, Ralić J, Radić Brkanac S, et al. (2015). Quantification of malondialdehyde by HPLC-FL – application to various biological samples. Biomed Chromatogr 29:41–6.
   PubMed Web of Science ®Google Scholar
• Engstrom G, Segelstrom N, Ekberg-Aronsson M, et al. (2009). Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax 64:211–15.
   PubMed Web of Science ®Google Scholar
• Franciosi LG, Page CP, Celli BR, et al. (2006). Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 19:189–99.
   PubMed Web of Science ®Google Scholar
• Frei B, Stocker R, Ames BN. (1988). Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85:9748–52.
   PubMed Web of Science ®Google Scholar
• Gajski G, Domijan AM, Garaj-Vrhovac V. (2012). Alterations of GSH and MDA levels and their association with bee venom-induced DNA damage in human peripheral blood leukocytes. Environ Mol Mutagen 53:469–77.
   PubMed Web of Science ®Google Scholar
• Galdstone M, Levytska V, Schwartz MS, Magnusson B. (1984). Ceruloplasmin. Increased serum concentration and impaired antioxidant activity in cigarette smokers, and ability to prevent suppression of elastase inhibitory capacity of alpha1-proteinase inhibitor. Am Rev Respir Dis 129:258–63.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Pulmonary Disease. (2011). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: updated 2011 [Online]. Available from: http://http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf [last accessed 15 Dec 2014].
   Google Scholar
• Gutteridge JMC. (1995). Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41:1819–28.
   PubMed Web of Science ®Google Scholar
• Hanta I, Kocabas A, Canacankatan N, et al. (2006). Oxidant-antioxidant balance in patients with COPD. Lung 184:51–5.
   PubMed Web of Science ®Google Scholar
• Healy J, Tipton K. (2007). Ceruloplasmin and what it might do. J Neural Transm (Vienna) 114:777–81.
   PubMed Web of Science ®Google Scholar
• Horsfall LJ, Rait G, Walters K, et al. (2011). Serum bilirubin and risk of respiratory disease and death. JAMA 305:691–7.
   PubMed Web of Science ®Google Scholar
• Hu ML. (1994). Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol 233:380–5.
   PubMed Web of Science ®Google Scholar
• Isik B, Isik SR, Yolacan H, Isik MR. (2005). Serum malonyldialdehyde and paraoxonase levels in chronic obstructive pulmonary disease. Turk Respir J 6:19–21.
   Google Scholar
• Jones PW, Agusti AGN. (2006). Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 27:822–32.
   PubMed Web of Science ®Google Scholar
• Kluchova Z, Petrašova D, Joppa P, et al. (2007). The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 56:51–6.
   PubMed Web of Science ®Google Scholar
• MacNee W. (2000). Oxidants/antioxidants and COPD. Chest 117:303S–17S.
   Google Scholar
• MacNee W. (2013). Systemic inflammatory biomarkers and comorbidities of chronic obstructive pulmonary disease. Ann Med 45:291–300.
   PubMed Web of Science ®Google Scholar
• Mak JCW. (2008). Pathogenesis of COPD. Part II. Oxidative–antioxidative imbalance. Int J Tuberc Lung Dis 12:368–74.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS. (2007). Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370:765–73.
   PubMed Web of Science ®Google Scholar
• Margarson MP, Soni N. (1998). Serum albumin: touchstone or totem? Anaesthesia 53:789–803.
   PubMed Web of Science ®Google Scholar
• Nicholson JP, Wolmarans MR, Park GR. (2000). The role of albumin in critical illness. Br J Anaesth 85:599–610.
   PubMed Web of Science ®Google Scholar
• Patel ARC, Hurst JR, Wedzicha JA. (2010). The potential value of biomarkers in diagnosis and staging of COPD and exacerbations. Semin Respir Crit Care Med 31:267–75.
   PubMed Web of Science ®Google Scholar
• Prakash M, Shetty MS, Tilak P, Anwar N. (2009). Total thiols: biomedical importance and their alteration in various disorders. Online J Health Allied Scs 8:2.
   Google Scholar
• Rahman I, MacNee (1996). Role of oxidants/antioxidants in smoking induced lung diseases. Free Radic Biol Med 21:669–81.
   PubMed Web of Science ®Google Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. (1996). Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 154:1055–60.
   PubMed Web of Science ®Google Scholar
• Rahman I, Swarska E, MacNee W. (1997). Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52:565–8.
   PubMed Web of Science ®Google Scholar
• Rahman I, Swarska E, Henry M, et al. (2000). Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55:189–93.
   PubMed Web of Science ®Google Scholar
• Rahman I. (2005). Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 43:167–88.
   PubMed Web of Science ®Google Scholar
• Roche M, Rondeau P, Singh NR, et al. (2008). The antioxidant properties of serum albumin. FEBS Lett 582:1783–7.
   PubMed Web of Science ®Google Scholar
• Rosenberg SH, Kalhan R. (2012). Biomarkers in chronic obstructive pulmonary disease. Transl Res 159:228–37.
   PubMed Web of Science ®Google Scholar
• Rumora L, Rajković MG, Kopčinović LM, et al. (2014). Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease. Copd 11:539–45.
   PubMedGoogle Scholar
• Santos MC, Oliveira AL, Viegas-Crespo AM, et al. (2004). Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 9:461–9.
   PubMed Web of Science ®Google Scholar
• Stites S, Nelson ME, Wesselius LJ. (1995). Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS. Chest 107:1681–5.
   PubMed Web of Science ®Google Scholar
• Tavilani H, Nadi E, Karimi J, Goodarzi MT. (2012). Oxidative stress in COPD patients, smokers, and non-smokers. Respir Care 57:2090–4.
   PubMed Web of Science ®Google Scholar
• Turino GM. (2008). COPD and biomarkers: the search goes on. Thorax 63:1032–4.
   PubMed Web of Science ®Google Scholar
• Verrills NM, Irwin JA, He XY, et al. (2011). Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183:1633–43.
   PubMed Web of Science ®Google Scholar
• Yanbaeva DG, Dentener MA, Creutzberg EC, et al. (2007). Systemic effects of smoking. Chest 131:1557–66.
   PubMed Web of Science ®Google Scholar